Investments
2Portfolio Exits
1Latest Gene Salkind News
Dec 5, 2018
Source: CBNB 2018/12/05 Source: Company press release, 1 Nov 2018 , 1 Nov 2018 , Website: http://www.globenewswire.com CURE Pharmaceutical, an innovative drug delivery and development company, has secured a $2 M investment at $2.5/share from Gene Salkind, a company advisor and biotech investor, bringing his total investment in the company to $3 M. In Feb 2018, Dr Salkind joined CURE's advisory board to help advance CURE's pipeline for the central nervous system and other therapeutic areas. Found on website: http://www.globenewswire.com. Released to ICIS 5 Dec 2018[This article was prepared by Chemical Business NewsBase (CBNB), a third party premium option available through ICIS news. For any queries about the content please contact: John Godfrey, godfreyj@elsevier.com, +44 (0) 1223 463167] SHARE THIS STORY
Gene Salkind Investments
2 Investments
Gene Salkind has made 2 investments. Their latest investment was in DermTech International as part of their Series B on August 8, 2013.
Gene Salkind Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
8/20/2013 | Series B | DermTech International | $5.6M | No | 2 | |
3/21/2008 | Series A |
Date | 8/20/2013 | 3/21/2008 |
|---|---|---|
Round | Series B | Series A |
Company | DermTech International | |
Amount | $5.6M | |
New? | No | |
Co-Investors | ||
Sources | 2 |
Gene Salkind Portfolio Exits
1 Portfolio Exit
Gene Salkind has 1 portfolio exit. Their latest portfolio exit was DermTech International on August 30, 2019.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
8/30/2019 | Reverse Merger | 3 |
Date | 8/30/2019 |
|---|---|
Exit | Reverse Merger |
Companies | |
Valuation | |
Acquirer | |
Sources | 3 |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.